Nasdaq
$16.59▼ 0.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.16BShares out 1.300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
15- 10.5After-hours26.10.06 05:294Ownership#●●●
NEOGENOMICS INC
Warren Stone, an officer of NeoGenomics, Inc., has filed a Power of Attorney authorizing designated representatives to prepare and submit SEC filings, including Forms 3, 4, 5, and Schedules 13D/13G, on his behalf. This filing establishes the legal authority for these representatives to manage his regulatory reporting obligations regarding company securities.…more
$16.59-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.5After-hours26.10.06 05:088-KKey event
NEOGENOMICS INC
NeoGenomics announced an executive succession plan effective January 4, 2027, appointing current President and COO Warren Stone as CEO, while current CEO Tony Zook will transition to Executive Chairman. The company also reported preliminary Q3 2026 revenue of approximately $209 million, with 28% NGS revenue growth, and expects to raise its full-year revenue guidance.…more
$16.59-0.09%vs prev closeView filingShare - 9.3After-hours26.09.04 06:014Ownership
NEOGENOMICS INC
Alicia C. Olivo, an insider at NeoGenomics Inc., reported a change in beneficial ownership of securities effective September 1, 2026. This filing formalizes the update regarding the insider's equity holdings.…more
$16.59-0.09%vs prev closeView filingShare
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15Pre-market26.10.15 20:14#●●●#●●●
NeoGenomics Expands Digital Pathology Partnership With Indica Labs
NeoGenomics is expanding its partnership with Indica Labs to scale digital pathology services using the HALO AP platform. The financial terms of the agreement were not disclosed.…more
$16.59-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.5After-hours26.10.06 05:11
●●●●●●●● ●●●●● ●●●●●●
NeoGenomics expects Q3 revenue of approximately $209 million and has reiterated its fiscal year 2026 financial targets. The company also announced plans to raise the midpoint of its annual revenue guidance during the upcoming Q3 earnings call.…more
$16.59-0.09%vs prev closeShareBenzinga - 10.5After-hours26.10.06 05:06
●●●●●●●● ●●●●● ●●●●●●
NeoGenomics announced that current COO Warren Stone will succeed Tony Zook as CEO, effective January 4, 2027. Tony Zook will transition to the role of Executive Chair to continue supporting the company's leadership.…more
$16.59-0.09%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report